Akiko Ishigami Selected Research

Paresis (Hemiparesis)

5/2014

Neurologic improvement without angiographic improvement after antithyroid therapy in a patient with Moyamoya syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akiko Ishigami Research Topics

Disease

4	Wounds and Injuries (Trauma) 03/2024 - 02/2006
4	Stroke (Strokes) 10/2023 - 02/2014
3	Thrombosis (Thrombus) 12/2023 - 02/2014
3	Rhabdomyolysis 01/2010 - 03/2003
2	Necrosis 01/2024 - 04/2023
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2024 - 11/2021
2	Inflammation (Inflammations) 11/2023 - 04/2023
2	Ischemic Stroke 01/2022 - 01/2022
2	Poisoning 03/2003 - 02/2003
1	Ischemia 01/2024
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2024
1	Liver Failure 04/2023
1	Abdominal Pain (Pain, Abdominal) 03/2023
1	Hemorrhagic Shock 03/2023
1	Hepatocellular Carcinoma (Hepatoma) 03/2023
1	Thrombasthenia (Glanzmann Thrombasthenia) 03/2023
1	Chronic Hepatitis C 03/2023
1	Fibrosis (Cirrhosis) 03/2023
1	Hemoperitoneum 03/2023
1	Arthralgia (Joint Pain) 02/2022
1	Necrotizing Fasciitis 02/2022
1	Proteinuria 01/2022
1	Drowning 03/2021
1	Cerebral Hemorrhage 01/2021
1	Moyamoya Disease (Moya-Moya Disease) 05/2014
1	Paresis (Hemiparesis) 05/2014
1	Embolism (Embolus) 02/2014
1	Embolic Stroke 02/2014
1	Malignant Hyperthermia 04/2009
1	Neuroleptic Malignant Syndrome 04/2009
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2006
1	Hypothermia 02/2006
1	Body Weight (Weight, Body) 01/2005
1	Cadaver (Cadavers) 07/2004
1	Acute Kidney Injury (Acute Renal Failure) 03/2003
1	Myoglobinuria 03/2003

Drug/Important Bio-Agent (IBA)

2	CreatinineIBA 11/2023 - 01/2022
2	vegetaminIBA 01/2010 - 04/2009
2	MyoglobinIBA 03/2003 - 02/2003
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2024
1	Fibronectins (Fibronectin)IBA 01/2024
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2024
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2023
1	sivelestatIBA 04/2023
1	Transaminases (Aminotransferases)IBA 04/2023
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2023
1	Hemoglobins (Hemoglobin)IBA 03/2023
1	Hyaluronic Acid (Hyaluronan)IBA 02/2022
1	UbiquitinIBA 01/2022
1	danaparoid (Orgaran)FDA Link 01/2022
1	Heme Oxygenase-1IBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 03/2021
1	Aquaporins (Water Channels)IBA 03/2021
1	CollagenIBA 03/2021
1	Heparin (Liquaemin)FDA LinkGeneric 02/2014
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 04/2009
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 04/2009
1	Hormones (Hormone)IBA 02/2006
1	TolueneIBA 01/2005
1	HLA-DQA1 antigen (HLA DQA1)IBA 07/2004
1	Methamphetamine (Desoxyn)FDA LinkGeneric 03/2003
1	8-Hydroxy-2'-DeoxyguanosineIBA 03/2003

Therapy/Procedure

6	Therapeutics 12/2023 - 02/2014
1	Radiofrequency Ablation 03/2023
1	Intra-Articular Injections 02/2022
1	Ligation 03/2021
1	Secondary Prevention 02/2014
1	Hypophysectomy 02/2006
1	Bone Nails 07/2004